In the BioHarmony Drug Report Database

"Preview" Icon

Urofollitropin

Bravelle (urofollitropin) is an unknown pharmaceutical. Urofollitropin was first approved as Bravelle on 2002-05-06. It is used to treat female infertility and polycystic ovary syndrome in the USA. The pharmaceutical is active against follicle-stimulating hormone receptor.

 

Trade Name

 

Bravelle
 

Common Name

 

urofollitropin
 

ChEMBL ID

 

CHEMBL1201520
 

Indication

 

female infertility, polycystic ovary syndrome
 

Drug Class

 

Tricyclic compounds; atropine derivatives

Image (chem structure or protein)

Urofollitropin structure rendering